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Objective. To assess the accuracy of hypertensive disorders of pregnancy reporting in
birth and hospital discharge data compared with data abstracted from medical
records. Methods. Data from a validation study of 1200 women provided the ‘gold
standard’ for hypertension status. The validation data were linked to both hospital
discharge and birth databases. Hypertension could be reported in one, both, or neither
database. Results. Of the 1184 records available for review, 8.3% of women had
pregnancy-related hypertension and 1.3% had chronic hypertension. Reporting sensi-
tivities ranged from 23% to 99% and specificities from 96% to 100%. Using broad
rather than specific categories of hypertension and more than one source to identify
hypertension improved case ascertainment. Women with severe preeclampsia or
adverse outcomes were more likely to have their pregnancy-related hypertension reported.
When the hypertension reporting was discordant on the birth and hospital discharge
data, the hospital data were more accurate. Conclusions. Pregnancy-related hyperten-
sion is reported with a reasonable level of accuracy, but chronic hypertension is mark-
edly under-ascertained, even when cases were identified from more than one source.
Milder forms of hypertension are more likely to go unreported. Studies utilizing popu-
lation health data may overestimate the proportion of more severe forms of disease and
any risk these conditions contribute to other outcomes.
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INTRODUCTION
Administrative or population health data sets (PHDS)—such as birth, hospital
discharge, pharmaceutical, and registry data—are being used increasingly to
evaluate health outcomes and health services (1–12). The population coverage
and availability of routinely collected PHDS make them an attractive and
inexpensive resource for research, allowing description of the total burden of
disease and interventions in the population, assessment of risk factors and
causal pathways, and investigation of rare outcomes (13,14). However, there
are limitations relating to the completeness and validity of data in studies
utilizing single datasets and potential misclassification of exposures and
outcomes (13,14). Linkage of PHDS can reduce the problem of under-
ascertainment if information is collected on more than one dataset, but this
allows the possibility of discrepant or discordant case reports (15–17).
Although it is has also been suggested that more severe conditions are likely
to be reported in PHDS, we are not aware of any studies that support this
conjecture (18).
Rates of the hypertensive disorders of pregnancy from PHDS range from
0.6% to 2.7% for chronic hypertension, 1.5% to 7.7% for preeclampsia, 4.2% to
7.9% for gestational hypertension, and 2.7/10 000 to 6.4/10 000 for eclampsia
(7–12). Although the reporting of hypertension in PHDS has been included in
several studies in general (19–21), high risk (22), and pregnant inpatient
populations (15,23–27) only one focussed specifically on hypertension reporting
(27). To our knowledge there are no published reports that validate discordant
case reports in linked population health data where cases are identified on
more than one data set, or assess the association between disease severity and
reporting. In addition, few studies have compared broad (e.g., pregnancy
hypertension) and specific (e.g., preeclampsia) diagnostic categories (19,21,28)
or hypertension reported using the more detailed Tenth Revision of the Inter-
national Classification of Disease (ICD10).
The principal aim of this study was to assess the accuracy of the hyperten-
sive disorders of pregnancy reporting in single and linked population health
datasets (birth and hospital discharge) compared with data abstracted from
medical records. In addition, we examined the accuracy of broad versus spe-
cific categorization of hypertension, determined whether women with severe
preeclampsia and poor outcomes were more likely to have their hypertension
reported in PHDS than women with less severe pregnancy hypertension and
determined which data source was more reliable when the PDHS reports were
discordant.Accuracy of Hypertension Reporting in Pregnancy 287
METHODS
New South Wales (NSW) is the most populous Australian state with a population
of ~6.8 million and 83,000 births per annum in over 100 hospitals, ranging
from small rural hospitals to seven tertiary centers. The population health
data were obtained from two NSW Department of Health computerized
datasets: the Midwives Data Collection (MDC) and the Admitted Patient Data
Collection (APDC). The MDC (referred to as ‘birth data’) is a population-based
surveillance system covering all NSW births ≥20 weeks gestation or ≥400 g
birthweight, and includes information on maternal characteristics, preg-
nancy, labor, delivery and infant outcomes. The APDC (referred to as ‘hospital
data’) is a census of all NSW inpatient hospital discharges; data are coded
from the medical records according to the Tenth revision of the International
Classification of Diseases (ICD10) (28). The NSW Department of Health per-
forms record linkage of the two datasets and produces de-identified linked
birth and hospital records. Hypertension is reported on both the birth and
hospital data. In the birth data, reporting is by check-boxes for chronic hyper-
tension and/or preeclampsia. In the hospital data, hypertension is reported
using the six major ICD10 codes for hypertension in pregnancy (O11-O16) and
a maximum of 40 diagnoses could be made for each hospital admission. We
compared hypertension reporting in a sample of records from these two data
collections with information abstracted from the corresponding medical
records. All women who gave birth in NSW in 2002 and who had a linked
birth-hospital record were eligible for the study.
Medical record data were obtained from a validation study of the reporting
of maternal medical and pregnancy conditions. The methods have been
described elsewhere (30). Briefly, the records of 1200 women giving birth in
2002 were randomly selected and data were abstracted from their medical
records by three clinicians experienced in chart review. To ensure reasonable
numbers of cases at hospitals providing maternity care for low-risk mothers,
small rural maternity hospitals were over-sampled. Although hospitals are
only required to record medical conditions that affect the current admission,
data were abstracted on any occurrence of hypertension during the pregnancy.
Abstracted data (referred to as ‘validation data’) were entered into an
electronic database and merged with data from the linked birth and hospital
population health datasets (PHDS) for analysis.
In the validation study, the clinical criterion for chronic hypertension was
hypertension (≥140 mm Hg systolic and/or ≥90 mm Hg diastolic) diagnosed
before conception or before 20 weeks gestation (31,32). Pregnancy-related
hypertension was diagnosed as arising after 20 weeks gestation and included
gestational hypertension, preeclampsia, and eclampsia. Preeclampsia was
hypertension with onset after 20 weeks gestation with one or more of pro-
teinuria, renal insufficiency, liver disease, neurological problems, hematological288 Roberts et al.
disturbances, or fetal growth restriction and where there was multi-organ
disease requiring urgent delivery this was classified as severe preeclampsia
(31–33). Gestational hypertension was defined as hypertension arising after
20 weeks gestation without other criteria of preeclampsia but resulting in
antenatal admission, antihypertensives, or induction of labor. Abstracters
noted whether a diagnosis was recorded and therefore likely to be coded, or
whether the clinical criteria were fulfilled but a diagnosis was not recorded.
The study was approved by the NSW Department of Health Ethics Committee.
Data Analysis
To provide unbiased estimates that are representative of the population,
all rates, estimates, and exact binomial confidence intervals (95%CI) were
weighted by the inverse of the sampling probabilities. Using the validation
data as the ‘gold standard’ for hypertension status, we calculated the sensitivity,
specificity, positive predictive value (PPV), and negative predictive value
(NPV) of PHDS reporting (34). The sensitivity denotes how completely a data
source (e.g., the birth data) identified hypertension compared with the ‘true’
hypertension status as determined by the validation data. The specificity
denotes correct ascertainment of the nonhypertensive state. The PPV denotes
how accurately the PHDS data source identifies hypertension and NPV for the
absence of hypertension. As the PPV is the most efficient and informative val-
idation strategy for low incidence conditions (35), the relative accuracy of the
different PHDS was assessed by comparing the PPVs using the test of two
proportions and a significance level of 0.05 (36). Agreement between the
PHDS (birth and hospital data) and the validation data was determined by
calculation of the kappa statistic, which adjusts for agreement that would be
observed on the basis of chance. Values greater than 0.75 represent excellent
agreement beyond chance, values 0.40 to 0.75 represent good agreement
beyond chance, and those below 0.40 represent poor agreement (36).
Pregnancy hypertension was used to explore whether reporting differed
by maternal age and parity, and whether more severe disease or poor infant or
maternal outcomes influenced reporting in the PHDS. The outcomes exam-
ined were preterm birth (<37 weeks gestation) and maternal morbidity
(a composite measure of major morbidity based on adverse events and medical
procedures) (30). The ‘true’ rate of adverse outcomes among women with preg-
nancy hypertension was determined using the validation data. Then among
women with pregnancy-related hypertension identified by the PHDS, the pro-
portion with validated adverse outcomes was determined and compared with
the ‘true’ rate. The test of two proportions was used to assess whether differ-
ences were greater than expected (p < 0.05) (36).
Finally we examined the impact of using different methods of classifying
records when the occurrence or type of hypertension was discordant on the
birth and hospital data. We compared the odds ratio (OR) of the associationAccuracy of Hypertension Reporting in Pregnancy 289
between pregnancy-related hypertension and maternal morbidity in the
validation data (the ‘true’ estimate of effect) with four previously reported
methods of classifying discordant records (17). The following situations were
considered partial agreement: one source reported gestational hypertension
and the other preeclampsia; reporting only one part of chronic hypertension
with superimposed preeclampsia; unspecified hypertension in the hospital data
and a type specified in the birth data; and reporting on only one PHDS (17).
RESULTS
Of the 1200 records selected, 1184 were available for review. The rates of
hypertension as determined by the medical record review, birth data, hospital
data, and linked data are presented in Table 1. The birth and hospital data
underestimated the rates of hypertension. The use of linked data (hyperten-
sion in either birth or hospital data) gave rates closer to those in the valida-
tion data. Only 12 (0.14%) women in the validation study had chronic
hypertension with superimposed preeclampsia.
In the validation data, 59 (0.9%) records fulfilled the clinical criteria for
severe preeclampsia, and all had a recorded diagnosis of preeclampsia (86%)
or pregnancy hypertension (14%). Ten (0.4%) records fulfilled the clinical
criteria for chronic hypertension, but no diagnosis was recorded in the medical
record and similarly for 7 (0.9%) women with gestational hypertension. Of
these, 44% and 9% respectively were reported in one or other PHDS.
Of the medical records reviewed, 642 (56%) were considered less than
complete, including 22% without antenatal clinic records and 20% private
patients. The rate of chronic hypertension was significantly higher (p = 0.03)
in those with complete documentation (2.1%) compared with those with
incomplete or no antenatal records (0.7%). However, there was no statistically
significant difference in the rate of pregnancy hypertension among women
with complete versus incomplete records (9.1 % versus 7.7%, p = 0.4).
Table 1: Rates of hypertension in the validation study and population health data 
sets (PHDS).
Type of hypertension
No. of 
“true” 
cases
Rates of hypertension by data source (%*)
Validation 
study
Birth 
data
Hospital 
data
Either birth 
or hospital 
data
Any hypertension 178 9.5 6.2 7.2 8.0
Any Chronic hypertension 25 1.3 0.5 0.6 0.8
Any Pregnancy hypertension 165 8.3 5.7 6.0 7.5
Gestational hypertension 72 6.2 3.8
Preeclampsia 93 2.1 2.3
*Percentages are weighted for the sampling probability.290 Roberts et al.
The hypertension reporting characteristics of the PHDS compared with
the validation data are shown in Table 2. For the specific types of hypertension,
sensitivities ranged from 23% to 85% and specificities from 96% to 100%.
Broad categorization of hypertension into any pregnancy-related hypertension
or any hypertension, increased the sensitivity with little impact on the
specificity, as did identifying cases for either PHDS. Kappa statistics were
also highest for the grouped hypertension categories and for hypertension
identified on either dataset. Sixteen of the 25 NPVs (data not shown) were
over 98.0%, ranging from 96.9% (95%CI, 95.4% to 97.6%) for gestational
hypertension to 100% for preeclampsia identified from either dataset. There
was a tendency for the hospital data to be more accurate than the birth data,
with generally higher PPVs, NPVs and kappa statistics for all the hyperten-
sive disorders. However, with the exception of preeclampsia reporting, the
differences were not statistically significant.
Table 2 also shows the pregnancy hypertension reporting characteristics
of the PHDS compared with the validation data stratified by maternal age
and parity. Among the study population 18.2% of women were aged ≥35 years,
and 39.9% were having their first baby. The reporting sensitivities and
kappas were higher for women aged <35 years but the PPVs were lower, and
the differences in reporting were not statistically significant. In contrast, the
PPV and NPV were significantly higher for primiparous women than for mul-
tiparous women when pregnancy hypertension was identified in either dataset.
In the validation data, 2 women (1.5/10,000) had eclampsia and while both
were identified in the hospital data, there were also 6 false-positives (2 with
preeclampsia and 4 with gestational hypertension but no record of convul-
sions) giving a PPV of only 23.5%.
All women identified as having severe preeclampsia in the validation
data were reported with pregnancy hypertension in the hospital data and
87% were reported in the birth data, higher than the overall sensitivities for
pregnancy hypertension (68% and 63% respectively); under-reporting was
concentrated among the less severe forms of pregnancy hypertension. Thus
the PHDS included a higher proportion of women with severe preeclampsia
than the ‘true’ rate in the validation data, although the differences were not
statistically significant (Table 3). Women with a preterm birth and/or maternal
morbidity were also more likely to have their pregnancy hypertension
reported in the PHDS (Table 3). Restricting analyses to women with preg-
nancy hypertension reported in both PHDS datasets resulted in an over-
representation of severe disease (as indicated by the highest rates of adverse
outcomes) and under-representation of milder disease or women who were
well managed. Accepting a report of pregnancy-related hypertension from
either data set identified the greatest number of women with pregnancy-
related hypertension and had rates of adverse outcomes closest to the ‘true’
rates.291
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Finally, we examined the 100 (6%) records where the PHDS had discor-
dant coding of hypertension including 3% where the hypertension was
reported in only one dataset. The hospital data included 9 (0.7%) with ‘unspec-
ified maternal hypertension’, and the majority of these (98.5%) were identified
as gestational hypertension in the validation study. Overall, the hospital data
were more reliable; of the discordant records, the hospital data were correct or
partially correct for 76% compared with only 22% for the birth data (p < 0.05).
Using the four published methods of classifying discordant records (17) gave
odds ratios (OR) for pregnancy-related hypertension and maternal morbidity
that ranged from 3.1 to 4.7 compared with the ‘true’ estimate of 3.4 (95%CI,
1.2 to 9.5) although the confidence intervals of all estimates overlapped.
Restricting the analysis to records with perfect agreement on hypertension
status gave the most extreme odds ratio (4.7; 95%CI, 1.2 to 17.8) while including
perfect and partial agreement gave an estimate that was closest to the ‘truth’
(3.2; 95%CI, 1.0 to 10.8).
DISCUSSION
This study reports the accuracy of PHDS in identifying the true prevalence of
the hypertensive disorders of pregnancy and is a validation study as opposed
to an audit of coding practices in which experienced coders independently
reassign ICD codes to a sample of hospital records (19). We have demonstrated
for the first time that the reporting of hypertension in pregnancy varies accord-
ing to the presence of risk factors and adverse outcomes and that hospital
discharge data should be used in preference to birth data when discrepancies
Table 3:  Rates of validated adverse outcomes by source of pregnancy hypertension 
report.
Data source
Women with 
pregnancy-
related 
hypertension,†
Validated outcomes %*
Severe 
preeclampsia
Preterm 
<37 weeks
Maternal 
morbidity
“True” pregnancy hypertension‡ 165 10.6 9.0 4.9
Hypertension Reporting Source
Birth data alone 109 14.5 13.0 6.5
Hospital data alone 142 15.5 13.2 6.9
Either hospital or birth data 157 12.8 11.0 5.7
Both hospital and birth data 94 18.7 16.7 8.4
*Weighted percentage of validated adverse outcomes among women with pregnancy
hypertension.
†Number of women in the validation study with pregnancy-related hypertension according to
the data source.
‡’True’ rates of adverse outcomes among women with any pregnancy-related hypertension,
according to the medical records. The subsequent rows show that those with severe disease
or poor outcomes are more likely to be reported in PHDS but the differences were not statisti-
cally significant (p > 0.1).Accuracy of Hypertension Reporting in Pregnancy 293
between the two data sources occur. Simultaneously validating two datasets
allowed the assessment of discordance between the datasets. We also found
that using broad rather than specific categories of hypertension and more
than one source to identify hypertension improved case ascertainment.
Quantification of under-reporting allows the adjustment of prevalence
estimates (38).
Although it has been previously demonstrated that reliance on single
PHDS is likely to result in under-reporting of disease prevalence, our findings
suggest that under-reporting is not random. Not only were women with severe
preeclampsia more likely to be reported than those with milder forms of
pregnancy hypertension, so were those with adverse maternal and infant out-
comes. Although the validation sample had insufficient power to demonstrate a
statistically significant association between severity of outcome and reporting,
there was a consistent tendency for disproportionate reporting in the PHDS of
women with adverse outcomes. This finding is unlikely to be explained by insuf-
ficient diagnostic fields (20), as there were 40 diagnosis fields available in our
hospital data and the maximum number used in this sample was 16. The
women whose diagnoses were most likely to remain unreported were those with
less severe disease or, perhaps more importantly for health services research,
those who were well managed and did not suffer an adverse outcome. We also
found that primiparous women were significantly more likely to have their
pregnancy hypertension reported than multiparous women, which could be
related to higher rates of preeclampsia and adverse outcomes in first pregnan-
cies (8). We have previously shown that reporting in PHDS varies by mode of
delivery (38). The association between reporting, risk factors and adverse out-
comes needs to be examined for other conditions and in other populations.
For rare outcomes such as eclampsia ,  i n  w h i c h  f e w e r  t h a n  1 %  o f  t h e
women have the condition, the number of false-positives can outweigh the
number of true positives resulting in a low PPV (<50%). Analyses relying on
conditions with low PPVs would include more false-positive reports than true
cases. The reporting of eclampsia has previously been identified as inaccurate
with PPVs of 6 to 50%, and should not be relied upon (15,27,39).
In audits of general hospital populations using ICD8, ICD9, and ICD10,
broader diagnostic categories have bee n  f o u n d  t o  b e  m o r e  r e l i a b l e  t h a n
individual diagnoses (19,21,28). As the International Classification of Diseases
does not provide clinical definitions of the hypertensive disorders of pregnancy,
we found considerable misclassification of gestational hypertension and preec-
lampsia in both data sets and collapsing these categories into a single preg-
nancy hypertension category improved the PPV. Further improvements in the
PPV were obtained by aggregating the pregnancy and chronic hypertension cat-
egories to ‘any hypertension.’ However, an ‘any hypertension’ variable may have
limited clinical utility because chronic and pregnancy hypertension have differ-
ent risk factors, care requirements and adverse event probabilities (8,31,32).294 Roberts et al.
Although record linkage improves case identification when conditions are
reported on more than one dataset, the researcher may be faced with discordant
diagnoses from different data sources (17). We have identified that half the
hypertension reporting discrepancies were due to under-reporting on one
dataset. Of the remaining discordant reports, over 99% involved misclassification
of gestational hypertension and preeclampsia or partial reporting of preec-
lampsia superimposed on chronic hypertension. In general, the hospital
discharge data were more reliable, and should be used in preference to birth
data collections. For specific research questions, the preferred method for
selecting cases of hypertension from PHDS might depend upon whether
hypertension is being examined as a risk factor or an outcome. If used as a
risk factor, it will be desirable to minimize under-reporting and include cases
identified from any data source. However, if preeclampsia is being studied as
an outcome of pregnancy, it might be preferable to identify confidently the
severe manifestations that adversely affect the pregnancy. Linked hospital
and birth data are useful for investigating major maternal morbidity as seri-
ous conditions are generally well reported (30).
It was not surprising that chronic hypertension was under-reported in
both data sources. In this study, data were abstracted on the basis of any
occurrence of hypertension during pregnancy. In contrast, hospital discharge
records are only required to include conditions that affect the current hospital
admission, and birth data are more accurate at recording birth events than
medical conditions (25). Thirty percent of the women with chronic hypertension
fulfilled the clinical criteria but did not have the diagnosis recorded. Some of
these records were coded as chronic hypertension in the hospital data indicating
that some coding is based on diagnostic criteria or recognizes diagnoses of
chronic conditions from previous admissions. Furthermore, the medical chart
may be a poor gold standard for chronic hypertension if the records are not
complete. There was a significant difference in the prevalence of chronic
hypertension among complete and incomplete records and the ‘true’ preva-
lence of chronic hypertension in pregnancy may be around 2%. Pregnancy-
related hypertension was not affected in the same way because pregnancy
hypertension was usually an important diagnosis in the birth admission. It is
important that clinicians ensure that records are complete and accurately
reflect the final diagnoses, risk factors, and outcomes. Longitudinal linkage of
population data to antenatal hospitalizations may also allow improved identi-
fication of chronic hypertension.
Although this study is based on perinatal data, the findings are likely to
be applicable to the linkage of any specialized health datasets that include
information on diagnoses or procedures. Increasing linkage of such datasets
and additional linkages with population health registries, such as stroke,
congenital anomaly and pharmaceuticals (1–12), will increase the need for
assessments of the usefulness and accuracy of the linked data.Accuracy of Hypertension Reporting in Pregnancy 295
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